3rd Circ. Got Doryx Product-Hopping Suit Wrong, Mylan Says
Mylan on Friday asked for the Third Circuit to reconsider a September decision affirming a dismissal of its antitrust suit against Warner Chilcott over acne medication Doryx, saying if the holding...To view the full article, register now.
Already a subscriber? Click here to view full article